Molecular and clonal biomarkers will be integrated into upcoming clinical trials to measure whether the therapy is successfully reducing the population of abnormal stem cells. This clinical strategy underscores the mission of Alethio Therapeutics, which recently closed a pivotal $90 million Series
Clinical data for Revolution Medicines’ new oral pancreatic cancer drug suggests the treatment can more than double the overall survival period for terminal patients. This breakthrough arrives at a pivotal moment, as the broader healthcare sector transitions from a multi-year period of relative s
Health care emerged as the second most important national priority for voters overall, trailing only the broader economy in its influence on the election. For many Americans, the ballot box became the primary mechanism for expressing deep-seated anxiety regarding the spiraling costs of medical
Starting January 1, 2027, the Medicare conversion factor will drop to $32.63 for clinicians who remain outside of advanced alternative payment models. This reduction signifies a broader strategy by the Centers for Medicare & Medicaid Services to dismantle the traditional "sick care
In a state where economic prosperity often masks the fragile financial foundations of its citizens, the skyrocketing cost of staying alive has transformed from a private burden into the defining battlefield of the upcoming gubernatorial election. As California maintains its status as the nation’s l
The lawsuit argues that EyeMed's inability to prevent this latest breach is part of a recurring pattern of security failures that have plagued the insurance provider since 2020. This legal action, initiated by plaintiff Christie Buonsante, comes just days after the vision care provider
